ELVN-001

· Enliven Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ELVN-001, covering 2025-07-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia [Phase 1]